The challenge of handling highly potent API and ADCs in analytical chemistry
European Pharmaceutical Review
JUNE 28, 2022
Some examples of HPAPIs are cytotoxic compounds and hormones such as oestrogen. A new compound of unknown potency and toxicity. Over 25 percent of total drugs worldwide are classified as containing HP compounds and 30 percent of product candidates in the development pipeline are also HPAPIs, showing that this trend will continue.
Let's personalize your content